Chemical industry – Page 62
-
BusinessWestlake Chemical to buy rival Axiall
US chemical manufacturer Axiall acquired by Westlake Chemical for $3.8 billion, after its earlier bid was rejected
-
Business
Merck & Co to buy Afferent for neurology drugs
Deal worth up to $1.25bn includes drug candidate for chronic coughs
-
BusinessJ&J to buy Vogue for haircare range
$3.3bn deal expands Johnson & Johnson’s consumer products segment
-
OpinionHow the chemical industry is voting in the EU referendum
UK trade bodies predominantly favour remaining in the EU
-
ResearchConnections in flow
MIT’s Klavs Jensen tells us how his research ranges in size from a chip, to a fridge to a shipping container
-
BusinessVertellus enters bankruptcy
Chemical maker files for Chapter 11 bankruptcy protection for its US operations and plans to auction the business
-
BusinessThermoFisher Scientific to buy electron microscope maker
Deal will expand lab equipment provider’s instrument portfolio for life and materials sciences
-
BusinessJazz Pharma buy out Celator in $1.5bn deal
Deal centres on promising leukaemia drug fast-tracked by the US Food and Drug Administration
-
BusinessFracking gets first UK approval for five years
Council says Third Energy can test existing borehole in North Yorkshire
-
NewsAkzoNobel sponsors colour garden at Chelsea Flower Show
Display celebrates plants that have been used historically to make dyes, and highlights a new project to capture nature’s structural colours in paint
-
BusinessIndia hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
-
BusinessUS tax rules force fertiliser merger to fall flat
CF Industries’ $8bn merger plan to relocate from US to Europe scuppered by regulatory changes
-
BusinessUS tax relief law benefits chemical makers
Bill provides mechanism to waive import tariffs on materials not available from domestic suppliers
-
BusinessMonsanto turns down Bayer offer
As global agrochemical companies consolidate, Monsanto rejects ‘inadequate’ $62bn offer from Bayer
-
BusinessWHO clarifies glyphosate risks
UN and WHO panel conclude the herbicide glyphosate is ‘unlikely’ to cause cancer at realistic exposure levels
-
-
BusinessMylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
-
BusinessPfizer to buy Anacor for eczema ointment
$5.2bn deal will bolster pharma giant’s inflammation and immunology drugs portfolio
-
Business
Honeywell spins off resins and chemicals unit
‘AdvanSix’ will separate by early 2017 and produce nylon, fertiliser and various chemical intermediates
-
NewsInsider trading scandal topples head of Taiwan’s top research body
President of umbrella organisation overseeing 24 research institutions caught up in investigation into offloading of biotech shares prior to poor results